Nimble Diagnostics secures a €2.5 million grant from the EIC Accelerator programme

Nimble Diagnostics has been awarded a €2.5 million grant from EIC Accelerator, a funding programme of the European Innovation Council and SMEs Executive Agency (EISMEA). This spin-off from the Germans Trias i Pujol Research Institute (IGTP), the Polytechnic University of Catalonia - BarcelonaTech (UPC) and the University of Barcelona (UB), is among the 47 selected companies from 15 countries, chosen from a pool of 648 proposals.

Agarose-based method shows potential in understanding extracellular vesicles' role in cancer metastasis

A collaborative study led by researchers from IGTP has revealed the promising possibilities of using an agarose spot migration assay to examine the ability of extracellular vesicles to attract other cells in a controlled environment. The study has been recently published in the journal BMC Biology.

‘Un bri de ciència’ dedicates an episode to stroke to commemorate World Stroke Day

The podcast from the Germans Trias i Pujol Research Institute (IGTP) launches a new episode titled "Stroke: a race against the clock"). Researcher and clinician Mònica Millán explains what everyone should know about this pathology, as well as the research her group is conducting to improve the lives of patients.

IGTP and EATRIS hold a workshop on translational research and innovation

On 23 October, the "Translational research and innovation through EATRIS" workshop was held at IGTP. The purpose of this event was to discuss the advances and perspectives of EATRIS both in Spain and in Europe, highlighting the research and innovation activity of the IGTP.

Collaborative study identifies potential targets to treat the most common childhood liver cancer

The research, led by Cima Universidad de Navarra, sheds light on new possibilities for addressing various types of cancer. This work has been carried out in collaboration with Dr Carolina Armengol, leader of IGTP’s Childhood Liver Oncology (C-LOG) group, a pioneer in the study of childhood liver cancer in Spain.

Two projects from IGTP funded by ”la Caixa” Foundation to transition their innovative research from the laboratory to patients

The first urine test that detects kidney fibrosis as an alternative to kidney biopsies, an initiative from the IVECAT group, and a project applying artificial intelligence to rapidly categorise stroke patients and enhance their recovery chances, from the Neurovascular Research group, are two of the fifteen projects from Catalan research centres selected within the 2023 call of the new CaixaImpulse Healthcare Innovation programme.

Self-sampling proves effective in diagnosing asymptomatic mpox

An article published in Nature Communications on the pilot study carried out in Catalonia to evaluate the self-collection of biological samples reveals the high acceptability of the proposal and the key role of diagnosis in people without symptoms of mpox.

Reviving a depleted immune system: an unmet goal for people on HIV treatment

A study has identified a molecule that could potentially be a target for the development of immunotherapies, led by IrsiCaixa AIDS Research Institute and spearheaded by Julia García-Prado, principal investigator at the same centre and scientific director of the Germans Trias i Pujol Research Institute (IGTP).

InMaM project: innovative immunotherapies to treat breast cancer

The collaborative project InMaM, part of the Complementary Plan for Biotechnology Applied to Health, involving both Catalonia and the Basque Country, aims to discover new immunotherapy-based treatments for metastatic breast cancer.

IGTP researchers engage in World Cancer Research Day with talks and workshops

• In collaboration with the Badalona City Council, a series of events and talks organised to mark the 40th anniversary of the Germans Trias Hospital will deal with topics related to science and health.
• The event on Sunday at the Badalona Museum is organised by Amics de Can Ruti and will feature researchers from the Germans Trias i Pujol Research Institute (IGTP) and the Catalan Institute of Oncology (ICO).